Alice B Gottlieb, MD, PhD Email Alice Gottlieb
- CLINICAL PROFESSOR | Dermatology
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Downtown-Union Square 212-844-8800 212-844-8800
Alice Bendix Gottlieb MD, PhD, Medical Director, Mount Sinai Beth Israel Dermatology, Kimberly and Eric J. Waldman Department of Dermatology at The Icahn School of Medicine at Mount Sinai, is a superb physician who has made a significant mark in the scientific fields of Dermatology and Rheumatology.
After graduating from Brandeis University Summa Cum Laude with Honors in Chemistry, Dr. Gottlieb entered the combined MD-PhD program at The Rockefeller University-Cornell University Medical College where she was one of the first females to be admitted into the program. She received her PhD from the Rockefeller University in 1979 followed by her MD at Cornell University Medical Center in 1980. Dr. Gottlieb entered The New York Hospital for her internal medicine residency, which she completed in 1982, followed by a rheumatology fellowship at the Hospital for Special Surgery completed in 1984 and returned to the New York Hospital for her dermatology residency which she completed in 1993. Dr. Gottlieb founded the Tufts Dermatology residency program (which formally was shared with Boston University) and served as Chair of Dermatology and Dermatologist-in-Chief of Tufts Medical Center. She also founded the Dermatology Division at UMDNJ-Robert Wood Johnson Medical School where she served as Professor of Medicine, Director of the Clinical Research Center and Founding Director of the Psoriasis Center of Excellence. Before joining the Mt Sinai faculty she was a Professor of Dermatology at New York Medical College in New York City.
Dr. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. Through a study she had published in Lancet in 2001, Dr. Gottlieb was the first to show the efficacy of TNF blockers as monotherapy for moderate to severe psoriasis. Her research led to multiple TNF blockers being FDA-approved for psoriasis which revolutionized the care of psoriasis and psoriatic arthritis patients. In addition, Dr. Gottlieb was one of the first scientists to demonstrate that psoriasis is a T cell mediated disease. She showed that treatment with a T cell-specific immunotoxin cleared psoriasis clinically and histologically. With her published studies and public presentations she has been able to convince pharmaceutical companies to use psoriasis as their proof-of-concept disease when testing new immunomodulators that may decrease T cell and dendritic cell cytokine production. So far, her research has affected drug development in psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease and transplantation.
Through her research, Dr. Gottlieb has authored over 412 peer-reviewed articles making appearances in journals, such as the Lancet, the Journal of Experimental Medicine, Journal of Investigative Dermatology, Archives of Dermatology, the Journal of the American Academy of Dermatology, the New England Journal of Medicine. Additionally, she has presented her research at more than 300 dermatology and rheumatology conferences in Asia, Europe and the United States, as well as the FDA and the National Academy of Sciences. In 2001, she was the recipient of the American Skin Association’s Psoriasis Research Achievement Award in recognition of her “important contributions to the scientific understanding of psoriasis.” In a survey of top psoriasis experts from around the world, Dr. Gottlieb came in first place with 1506 first author citations. She continues her innovative clinical research at Mount Sinai.
In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple boarded in dermatology, rheumatology and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents and fellows she has trained, as well as the dermatologic community at large, who want to understand how to diagnose and manage psoriatic arthritis. She is an excellent teacher which is why it is no surprise she has won the Excellence in Teaching Award from the Department of Dermatology at Tufts University Medical School/Tufts Medical Center. In 2016 she received their National Psoriasis Foundation Outstanding Educator in Psoriatic Disease Award. In 2018, she was honored with an award from the National Psoriasis Foundation for her leadership in psoriasis and psoriatic arthritis research and care.
Dr. Gottlieb is the recipient of numerous awards including Excellence in Teaching Award from the Department of Dermatology at Tufts University Medical School/Tufts Medical Center, Honorary Membership in Alpha Omega Alpha in recognition of medical student teaching, a Research Mentorship award from the Internal Medicine house staff and a Mentorship Award from the American Chemical Society for mentoring minority high school students in bench and clinical research. She was elected to the Board of Directors of the American Academy of Dermatology for 2011-2015.She is a member of the American Dermatologic Association and others.
Over the course of her illustrious career, she held many important leadership positions the Board of Directors for the American Academy of Dermatology and the Women’s Dermatologic Society, and Chairman, Networking Committee of the Women’s Dermatologic Society, as well serving as a Medical Advisory Board member and Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis, which is physicians’ journal of the National Psoriasis Foundation. In 2015, she has been awarded the Honorary Membership into the American Academy of Dermatology for her exceptional leadership and service.
Dr. Gottlieb has served on the Editorial Board of the Journal of Cutaneous Medicine and Surgery and American Academy of Dermatology, the American Clinical Dermatology, Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis and Editor, Dermatology Section of Clinical Immunology. She is also an elected member of the Noah Worcester Dermatologic Society and the Association of Professors of Dermatology.
She is the founder and President of the International Dermatology Outcome Measures (IDEOM) group. Founded in 2013, this 501c3 non-profit, consortium of patients, physicians, pharmaceutical scientists and other stakeholders is dedicated to bringing outcome measures to dermatologic clinical research and practice that satisfy the needs of all stakeholders. She is on the Executive Board of GRAPPA, the group devoted the research in psoriasis and psoriatic arthritis. She is a councilor of the International Psoriasis Council.
Dr. Gottlieb practices at the Mount Sinai Beth Israel where she puts her patients first and she conducts her innovative clinical research in psoriasis, psoriatic arthritis, hidradenitis suppurativa and vitiligo and other immune mediated disorders.
She continues to enjoy her mentoring and teaching of the dermatology residents, junior faculty and medical students.
American Board of Dermatology
American Board of Internal Medicine
- Adolescent Dermatology
- Allergic Contact Dermatitis
- Alopecia Areata
- Atopic Dermatitis
- Autoimmune Diseases
- Bullous Pemphigoid
- Contact Dermatitis
- General Dermatology
- Pigmentary Disorders
- Polycystic Ovary Syndrome
- Psoriasis Vulgaris
- Psoriatic Arthritis
- Pyoderma Gangrenosum
- Seborrheic Dermatitis
- Skin Biopsy
- Skin Rashes
MD,PHD, Cornell University Medical College
Residency, Internal Medicine
New York Hospital
Hospital for Special Surgery
EnglishDownload the CV
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Gottlieb did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.